A Win For Calithera Biosciences, Inc.
Wed, Sep 25, 2024 at 07:40 PM
Calithera Biosciences, Inc. (CALA:NASDAQ) shot up at $0.03, a gain of 50%. From Wed, Sep 11, 2024, the stock recorded 16.67% Up Days and 71.43% Green Days
About Calithera Biosciences, Inc. (CALA:NASDAQ)
Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Top 10 Gainers:
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- Markforged Holding Corporation (MKFG:NYSE), 73.99%
- Vinco Ventures Inc. (BBIG:NASDAQ), 66.67%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 55.58%
- Rezolve AI Limited (RZLV:NASDAQ), 52.85%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 50%
- Alpha Technology Group Limited (ATGL:NASDAQ), 46.26%
- Eightco Holdings Inc Com (New) (OCTO:NASDAQ), 45.78%
- Motorsport Games Inc. (MSGM:NASDAQ), 38.74%
- Tenon Medical Inc. (TNON:NASDAQ), 34.08%